JP4556039B2 - ペルゴリド含有経皮吸収治療システム（ｔｔｓ） - Google Patents

ペルゴリド含有経皮吸収治療システム（ｔｔｓ） Download PDF

Info

Publication number
JP4556039B2
JP4556039B2 JP2000549223A JP2000549223A JP4556039B2 JP 4556039 B2 JP4556039 B2 JP 4556039B2 JP 2000549223 A JP2000549223 A JP 2000549223A JP 2000549223 A JP2000549223 A JP 2000549223A JP 4556039 B2 JP4556039 B2 JP 4556039B2
Authority
JP
Japan
Prior art keywords
pergolide
tts
meth
skin
active substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2000549223A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002515424A (ja
Inventor
アルト クリストフ
コルマイヤー−ゼーガー アンドレアス
リムプラー シュテファン
ヴォルフ ハンス−ミヒャエル
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB Pharma GmbH
Original Assignee
UCB Pharma GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCB Pharma GmbH filed Critical UCB Pharma GmbH
Publication of JP2002515424A publication Critical patent/JP2002515424A/ja
Application granted granted Critical
Publication of JP4556039B2 publication Critical patent/JP4556039B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
JP2000549223A 1998-05-15 1999-05-12 ペルゴリド含有経皮吸収治療システム（ｔｔｓ） Expired - Fee Related JP4556039B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19821788.9 1998-05-15
DE19821788A DE19821788C1 (de) 1998-05-15 1998-05-15 Transdermales Therapeutisches System (TTS) Pergolid enthaltend
PCT/EP1999/003278 WO1999059558A1 (de) 1998-05-15 1999-05-12 Transdermales therapeutisches system (tts) pergolid enthaltend

Publications (2)

Publication Number Publication Date
JP2002515424A JP2002515424A (ja) 2002-05-28
JP4556039B2 true JP4556039B2 (ja) 2010-10-06

Family

ID=7867847

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000549223A Expired - Fee Related JP4556039B2 (ja) 1998-05-15 1999-05-12 ペルゴリド含有経皮吸収治療システム（ｔｔｓ）

Country Status (20)

Country Link
US (1) US6461636B1 (xx)
EP (1) EP1077688B1 (xx)
JP (1) JP4556039B2 (xx)
KR (1) KR100507266B1 (xx)
CN (1) CN1190189C (xx)
AT (1) ATE210432T1 (xx)
AU (1) AU743229C (xx)
BR (1) BR9910404B1 (xx)
CA (1) CA2327187C (xx)
DE (2) DE19821788C1 (xx)
DK (1) DK1077688T3 (xx)
ES (1) ES2167116T3 (xx)
HK (1) HK1037541A1 (xx)
IL (1) IL138005A (xx)
MX (1) MXPA00011253A (xx)
NO (1) NO329042B1 (xx)
PL (1) PL192213B1 (xx)
PT (1) PT1077688E (xx)
WO (1) WO1999059558A1 (xx)
ZA (1) ZA200004670B (xx)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE44145E1 (en) 2000-07-07 2013-04-09 A.V. Topchiev Institute Of Petrochemical Synthesis Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
DE10033855A1 (de) * 2000-07-12 2002-01-31 Hexal Ag Matrixkontrolliertes transdermales System mit Sulfonsäuresalz eines ACE-Hemmers
DE10043321B4 (de) * 2000-08-24 2005-07-28 Neurobiotec Gmbh Verwendung eines transdermalen therapeutischen Systems zur Behandlung der Parkinsonschen Krankheit, zur Behandlung und Prävention des prämenstruellen Syndroms und zur Lactationshemmung
DE10341317B4 (de) * 2003-09-03 2008-10-23 Axxonis Pharma Ag Transdermales therapeutisches System (TTS) zur Verabreichung von Ergolinverbindungen ausgenommen Pergolid
DE10053397A1 (de) 2000-10-20 2002-05-02 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
DE10064453A1 (de) * 2000-12-16 2002-07-04 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
GB0102342D0 (en) * 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
BR0207955A (pt) * 2001-03-07 2004-02-25 Hisamitsu Pharmaceutical Co Agente de emplastro
US8206738B2 (en) 2001-05-01 2012-06-26 Corium International, Inc. Hydrogel compositions with an erodible backing member
US20050113510A1 (en) 2001-05-01 2005-05-26 Feldstein Mikhail M. Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
RU2276998C2 (ru) 2001-05-01 2006-05-27 Институт Нефтехимического Синтеза Имени А.В. Топчиева Российской Академии Наук Гидрогелевые композиции
US8840918B2 (en) 2001-05-01 2014-09-23 A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences Hydrogel compositions for tooth whitening
US20050215727A1 (en) 2001-05-01 2005-09-29 Corium Water-absorbent adhesive compositions and associated methods of manufacture and use
US8541021B2 (en) 2001-05-01 2013-09-24 A.V. Topchiev Institute Of Petrochemical Synthesis Hydrogel compositions demonstrating phase separation on contact with aqueous media
EP2277556B1 (en) 2001-05-01 2016-04-20 A. V. Topchiev Institute of Petrochemical Synthesis Two-phase, water-absorbent bioadhesive composition
DE10234673B4 (de) 2002-07-30 2007-08-16 Schwarz Pharma Ag Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren
JP4792193B2 (ja) * 2002-08-28 2011-10-12 久光製薬株式会社 貼付剤
JP4213432B2 (ja) * 2002-08-28 2009-01-21 久光製薬株式会社 貼付剤
DE10252863B4 (de) 2002-11-12 2007-04-19 Kronotec Ag Holzfaserplatte, insbesondere Fussbodenpaneel
US7617651B2 (en) 2002-11-12 2009-11-17 Kronotec Ag Floor panel
ATE395481T1 (de) 2002-11-15 2008-05-15 Flooring Technologies Ltd Einrichtung bestehend aus zwei miteinander verbindbaren bauplatten und einem einsatz zum verriegeln dieser bauplatten
DE10306118A1 (de) 2003-02-14 2004-09-09 Kronotec Ag Bauplatte
US7678425B2 (en) 2003-03-06 2010-03-16 Flooring Technologies Ltd. Process for finishing a wooden board and wooden board produced by the process
DE20304761U1 (de) 2003-03-24 2004-04-08 Kronotec Ag Einrichtung zum Verbinden von Bauplatten, insbesondere Bodenpaneele
DE10362218B4 (de) 2003-09-06 2010-09-16 Kronotec Ag Verfahren zum Versiegeln einer Bauplatte
DE20315676U1 (de) 2003-10-11 2003-12-11 Kronotec Ag Paneel, insbesondere Bodenpaneel
TW200514582A (en) * 2003-10-31 2005-05-01 Hisamitsu Pharmaceutical Co Transdermal preparation and method for reducing side effect in pergolide therapy
WO2005072669A1 (ja) * 2004-01-30 2005-08-11 Hisamitsu Pharmaceutical Co., Inc. カバー材及びカバー材付き貼付剤
US8658201B2 (en) 2004-01-30 2014-02-25 Corium International, Inc. Rapidly dissolving film for delivery of an active agent
DE102004011931B4 (de) 2004-03-11 2006-09-14 Kronotec Ag Dämmstoffplatte aus einem Holzwerkstoff-Bindemittelfaser-Gemisch
US20080038328A1 (en) * 2004-05-28 2008-02-14 Naruhito Higo Pasting Preparation
AU2005271259B2 (en) 2004-08-05 2012-01-19 A.V. Topchiev Institute Of Petrochemical Synthesis Adhesive composition
TW200633723A (en) * 2005-01-27 2006-10-01 Corium Int Inc Hydrophilic biocompatible adhesive formulations and uses
WO2006082728A1 (ja) * 2005-02-04 2006-08-10 Hisamitsu Pharmaceutical Co., Inc. 経皮吸収貼付剤
DE102005042658B3 (de) 2005-09-08 2007-03-01 Kronotec Ag Bauplatte, insbesondere Fußbodenpaneel
US7854986B2 (en) 2005-09-08 2010-12-21 Flooring Technologies Ltd. Building board and method for production
DE102005042657B4 (de) 2005-09-08 2010-12-30 Kronotec Ag Bauplatte und Verfahren zur Herstellung
DE102005063034B4 (de) 2005-12-29 2007-10-31 Flooring Technologies Ltd. Paneel, insbesondere Bodenpaneel
DE102006007976B4 (de) 2006-02-21 2007-11-08 Flooring Technologies Ltd. Verfahren zur Veredelung einer Bauplatte
EP2387394B1 (en) 2009-01-14 2018-05-02 Corium International, Inc. Transdermal administration of tamsulosin
AU2015277554C1 (en) 2014-06-18 2018-05-31 Audevard Transdermal formulations of pergolide and uses thereof
US9988337B2 (en) 2014-09-10 2018-06-05 Council Of Scientific And Industrial Research Single step process for the preparation of butyl acetate
TW201946617A (zh) 2017-04-28 2019-12-16 日商日東電工股份有限公司 經皮吸收製劑

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2075517C (en) * 1992-04-01 1997-03-11 John Wick Transdermal patch incorporating a polymer film incorporated with an active agent
DE4310012A1 (de) * 1993-03-27 1994-09-29 Roehm Gmbh Dermales therapeutisches System aus einer schmelzfähigen Poly(meth)acrylat-Mischung
US6572879B1 (en) * 1995-06-07 2003-06-03 Alza Corporation Formulations for transdermal delivery of pergolide
CA2259353C (en) * 1996-07-02 2006-09-05 Hexal Ag Plaster for the transdermal application of pergolide
DE19626621A1 (de) * 1996-07-02 1998-01-08 Hexal Ag Pflaster zur transdermalen Anwendung von Pergolid
DE19728517C2 (de) * 1997-07-04 1999-11-11 Sanol Arznei Schwarz Gmbh TTS zur Verabreichung von Sexualsteroidhormonen und Verfahren zu seiner Herstellung

Also Published As

Publication number Publication date
ATE210432T1 (de) 2001-12-15
MXPA00011253A (es) 2003-05-19
NO20004859L (no) 2000-09-27
NO20004859D0 (no) 2000-09-27
KR20010042685A (ko) 2001-05-25
DK1077688T3 (da) 2002-04-02
JP2002515424A (ja) 2002-05-28
IL138005A (en) 2005-07-25
NO329042B1 (no) 2010-08-02
ZA200004670B (en) 2000-11-22
PL344160A1 (en) 2001-10-08
BR9910404B1 (pt) 2009-12-01
EP1077688B1 (de) 2001-12-12
AU743229C (en) 2003-03-20
DE19821788C1 (de) 1999-12-02
AU743229B2 (en) 2002-01-24
PT1077688E (pt) 2002-05-31
AU4040799A (en) 1999-12-06
US6461636B1 (en) 2002-10-08
CN1301152A (zh) 2001-06-27
DE59900548D1 (de) 2002-01-24
HK1037541A1 (en) 2002-02-15
PL192213B1 (pl) 2006-09-29
WO1999059558A1 (de) 1999-11-25
KR100507266B1 (ko) 2005-08-10
CA2327187A1 (en) 1999-11-25
IL138005A0 (en) 2001-10-31
EP1077688A1 (de) 2001-02-28
ES2167116T3 (es) 2002-05-01
BR9910404A (pt) 2001-01-09
CA2327187C (en) 2005-12-27
CN1190189C (zh) 2005-02-23

Similar Documents

Publication Publication Date Title
JP4556039B2 (ja) ペルゴリド含有経皮吸収治療システム（ｔｔｓ）
AU749474B2 (en) Transdermal therapeutic system (TTS) for administering sexual steroid hormones
US6783769B1 (en) Transdermal therapeutic system TTS containing tolterodine
US6555131B1 (en) Therapeutical system for transdermal delivery of levonorgestrel
US20160158161A1 (en) Plaster containing fentanyl
US6555129B1 (en) Transdermal therapeutic system (TTS) containing oxybutynin
JP2869167B2 (ja) 徐放性貼付製剤
MXPA00000079A (en) Transdermal therapeutic system (tts) for administering sexual steroid hormones
MXPA00000065A (en) Therapeutical system for transdermal delivery of levonorgestrel

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060501

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091030

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100125

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20100603

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20100702

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130730

Year of fee payment: 3

LAPS Cancellation because of no payment of annual fees